<p>Analysis of viable tendon cells in human primary cultures after 24 hours of incubation with SP (10<sup>−7</sup> M), without SP (control), and with SP and the NK-1 R blocker (10<sup>−6</sup> M), as measured with crystal violet staining. The significant increase in viable cells seen after incubation with SP is effectively blocked with the NK-1 R antagonist. Error bars indicate standard deviation. *p<0.05; **p<0.01.</p
<p>(A) Growth curves of SP and NSP cells. SP cells in KRC/Y showed a higher proliferative ability co...
<p>A, NSCLC cell lines were treated with 10 μM tnv-1. After three (3 d) and five (5 d) days the prol...
<p>Cell survival was monitored 72 hours post IFN treatment by crystal violet staining. The fraction ...
<p>The mean fraction of proliferating (BrdU-positive) tendon cells in human primary cultures after 4...
<p>The mean fraction of proliferating (BrdU-positive) tendon cells in human primary cultures after i...
<p>Incubating human tendon cells with SP (10<sup>−7</sup> M) for 48 hours significantly increases th...
<p>RCC cells (Caki-1 and 786-O) were treated with DMSO, WY14,643 (WY), or GW6471 (GW) at the indicat...
<p>(A) Cultured neurons at 14 DIV were treated with DHPG (filled boxes, 10 µM, 10 min) with or witho...
Background It has been hypothesised that an upregulation of the neuropeptide substance P (SP) and it...
<p>qPCR analysis for SP (<b>a</b>) and NK-1 R (<b>b</b>) mRNA, respectively, in cultured human prima...
<p>Approximately 5% of human NS cells remained viable after 5 days exposure to the antimitotic drug ...
<p>A: Cell viability was normalised to 100%, and the relative viability of serum-starved cells was d...
<p>Soluble VEGF was measured in cell culture supernatants from SK-RC-45 and SK-RC-54 human RCC cultu...
<p>(A) Western blot analysis of SCD1-KO cell lysates; actin was used as a loading control. (B) Growt...
<p>Caki-1 (<b>A</b>, <b>B</b>) and 786-O (<b>C</b>, <b>D</b>) cells were plated on 96-well tissue-cu...
<p>(A) Growth curves of SP and NSP cells. SP cells in KRC/Y showed a higher proliferative ability co...
<p>A, NSCLC cell lines were treated with 10 μM tnv-1. After three (3 d) and five (5 d) days the prol...
<p>Cell survival was monitored 72 hours post IFN treatment by crystal violet staining. The fraction ...
<p>The mean fraction of proliferating (BrdU-positive) tendon cells in human primary cultures after 4...
<p>The mean fraction of proliferating (BrdU-positive) tendon cells in human primary cultures after i...
<p>Incubating human tendon cells with SP (10<sup>−7</sup> M) for 48 hours significantly increases th...
<p>RCC cells (Caki-1 and 786-O) were treated with DMSO, WY14,643 (WY), or GW6471 (GW) at the indicat...
<p>(A) Cultured neurons at 14 DIV were treated with DHPG (filled boxes, 10 µM, 10 min) with or witho...
Background It has been hypothesised that an upregulation of the neuropeptide substance P (SP) and it...
<p>qPCR analysis for SP (<b>a</b>) and NK-1 R (<b>b</b>) mRNA, respectively, in cultured human prima...
<p>Approximately 5% of human NS cells remained viable after 5 days exposure to the antimitotic drug ...
<p>A: Cell viability was normalised to 100%, and the relative viability of serum-starved cells was d...
<p>Soluble VEGF was measured in cell culture supernatants from SK-RC-45 and SK-RC-54 human RCC cultu...
<p>(A) Western blot analysis of SCD1-KO cell lysates; actin was used as a loading control. (B) Growt...
<p>Caki-1 (<b>A</b>, <b>B</b>) and 786-O (<b>C</b>, <b>D</b>) cells were plated on 96-well tissue-cu...
<p>(A) Growth curves of SP and NSP cells. SP cells in KRC/Y showed a higher proliferative ability co...
<p>A, NSCLC cell lines were treated with 10 μM tnv-1. After three (3 d) and five (5 d) days the prol...
<p>Cell survival was monitored 72 hours post IFN treatment by crystal violet staining. The fraction ...